9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine

9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine Suppliers list
Company Name: Zhengzhou Granlen Sciences, ltd.  
Tel: 0371-85513397 +86-18610099868
Email: info@granlen.com
Company Name: NewCan Biotech Limited  
Tel: +86-571-86912261 19975279805
Email: sales@newcanbio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Shanghai meikai technology co., ltd  
Tel: 021-68689288 15300790979
Email: info@mkbio.com.cn
Company Name: Zhejiang Tianmei Bioengineering Co., Ltd.  
Tel: 18957127338 15336502278
Email: 3007630027@qq.com

9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine manufacturers

9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine Basic information
Product Name:9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine
Synonyms:9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine;2-Chloro-9-(3-deoxy-3-fluoro-β-D-ribofuranosyl)-6-(3-thienyl)-9H-purine;9H-Purine, 2-chloro-9-(3-deoxy-3-fluoro-β-D-ribofuranosyl)-6-(3-thienyl)-;N-[3-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-(2-methoxyethoxy)oxolan-2-yl]-5-methyl-2-oxo-1,6-dihydropyrimidin-6-yl]benzamide
CAS:1612192-01-4
MF:C14H12ClFN4O3S
MW:370.78
EINECS:
Product Categories:
Mol File:1612192-01-4.mol
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine Structure
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine Chemical Properties
Boiling point 552.7±60.0 °C(Predicted)
density 1.88±0.1 g/cm3(Predicted)
pka12.40±0.70(Predicted)
Safety Information
MSDS Information
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine Usage And Synthesis
Uses2-Chloro-6-(thiophen-3-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine Preparation Products And Raw materials
Tag:9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-2-chloro-6-(thiophen-3-yl)purine(1612192-01-4) Related Product Information
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(thiophen-3-yl)purine 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(naphthalen-1-yl)purine 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(pyridine-4-yl)purine 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-methylpiperazinyl) pyridin-3-yl]purine 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-phenylpurine 9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)purine 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(5-phenylpyridin-3-yl)purine 6-Methylpurine-beta-D-(3-deoxy-3-fluoro)riboside 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[5-(propyn-1-yl)pyridin-3-yl]purine 9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-morpholinyl)pyridin-3-yl]purine